Furalazine

This classification denotes an anti-infective agent with the molecular formula C9H7N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2133JVQ6VE, chemically known as 1,2,4-triazin-3-amine, 6-(2-(5-nitro-2-furanyl)ethenyl)- (9ci) but more generally known as furalazine, which bears US NIH Compound Identifier 6436102. European Medicines Agency schedules Furalazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07830MIG. The term FURALAZINE is an International Non-Proprietary Name. FURALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule furalazine under HS 29349990 and SITC 51579. As of Q4 2014, FURALAZINE remains the US FDA Preferred Term for this commodity. Furalazine bears US NLM identifiers UMLS ID C0603287 and NCI Concept Code C65780. SMILES: O1C(CCC1[N](=O)O)/C=C/C1NNC(NC1)N.